← Back to all trials
Not Yet Recruiting
NCT07799675
Telerehabilitation in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension (PAH)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 34
Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Location: FIMABIS Málaga Málaga
Summary
Context: Pulmonary arterial hypertension (PAH) causes severe exercise intolerance and reduced quality of life, while access to supervised rehabilitation remains limited.
Objective: Evaluate the safety, feasibility, and clinical effects of an 8-week structured home-based telerehabilitation program in stable PAH patients. Methods: A multicenter, prospective, single-arm study including 34 adults with Group 1 PAH (WHO functional class II-III) performing three weekly exercise sessions via a digital platform.
Outcomes: The primary endpoint is peak oxygen consumption (VO₂peak) via cardiopulmonary exercise testing, alongside 6-minute walk distance, quality of life questionnaires, inflammatory biomarkers, and safety tracking.
Eligibility Criteria
Inclusion Criteria:
* Confirmed diagnosis of stable pulmonary arterial hypertension (PAH).
* Age 18 years or older.
* Ability to use a smartphone or mobile application for the telerehabilitation program.
* Signed informed consent.
Exclusion Criteria:
* Acute cardiorespiratory instability or medical contraindication to physical exercise.
* Cognitive impairment or psychiatric disorders preventing comprehension or use of the telerehabilitation program.
* Simultaneous participation in another interventional clinical trial.
Source: ClinicalTrials.gov (NCT07799675). StuddyBuddy aggregates publicly available trial information.
